$MOH
MOLINA HEALTHCARE, INC. Stock $moh

$moh Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000117992917000172 Filed on August 02, 2017

Income Statement

Concept	2017 Q2	2016 Q2
Revenue	$4.999B	$4.359B
YoY Change	14.68%	23.66%
Cost Of Revenue	$4.615B	$3.710B
YoY Change	24.39%	25.24%
Gross Profit	$254.0M	$466.0M
YoY Change	-45.49%	19.79%
Gross Profit Margin	5.08%	10.69%
Selling, General & Admin	$519.0M	$510.0M
YoY Change	1.76%	20.91%
% of Gross Profit	204.33%	109.44%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$47.00M	$45.00M
YoY Change	4.44%	52.54%
% of Gross Profit	18.5%	9.66%
Operating Expenses	$556.0M	$544.0M
YoY Change	2.21%	21.73%
Operating Profit	-$287.0M	$105.0M
YoY Change	-373.33%	-9.48%
Interest Expense	$27.00M	$25.00M
YoY Change	8.0%	66.67%
% of Operating Profit		23.81%
Other Income/Expense, Net	-$27.00M	-$25.00M
YoY Change	8.0%	-266.67%
Pretax Income	-$314.0M	$80.00M
YoY Change	-492.5%	-20.79%
Income Tax	-$84.00M	$47.00M
% Of Pretax Income		58.75%
Net Earnings	-$230.0M	$33.00M
YoY Change	-796.97%	-15.38%
Net Earnings / Revenue	-4.6%	0.76%
Basic Earnings Per Share	-$4.10	$0.58
Diluted Earnings Per Share	-$4.10	$0.58
COMMON SHARES
Basic Shares Outstanding	56.00M shares	55.00M shares
Diluted Shares Outstanding	56.00M shares	55.00M shares

Balance Sheet

Concept	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.171B	$4.313B
YoY Change	19.89%	23.92%
Cash & Equivalents	$2.979B	$2.345B
Short-Term Investments	$2.192B	$1.968B
Other Short-Term Assets	$924.0M	$197.0M
YoY Change	369.04%	32.56%
Inventory
Prepaid Expenses
Receivables	$1.006B	$1.012B
Other Receivables	$68.00M	$23.00M
Total Short-Term Assets	$7.169B	$5.545B
YoY Change	29.29%	15.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$449.0M	$448.0M
YoY Change	0.22%	23.33%
Goodwill	$559.0M	$611.0M
YoY Change	-8.51%	124.59%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$47.00M	$39.00M
YoY Change	20.51%	3.14%
Total Long-Term Assets	$1.414B	$1.657B
YoY Change	-14.67%	78.19%
TOTAL ASSETS
Total Short-Term Assets	$7.169B	$5.545B
Total Long-Term Assets	$1.414B	$1.657B
Total Assets	$8.583B	$7.202B
YoY Change	19.18%	25.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$375.0M	$537.0M
YoY Change	-30.17%	34.52%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$773.0M	$1.000M
YoY Change	77200.0%	-99.78%
Total Short-Term Liabilities	$5.793B	$3.646B
YoY Change	58.89%	-2.47%
LONG-TERM LIABILITIES
Long-Term Debt	$1.017B	$1.626B
YoY Change	-37.45%	242.82%
Other Long-Term Liabilities	$54.00M	$38.00M
YoY Change	42.11%	22.21%
Total Long-Term Liabilities	$1.071B	$1.664B
YoY Change	-35.64%	5251.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.793B	$3.646B
Total Long-Term Liabilities	$1.071B	$1.664B
Total Liabilities	$7.062B	$5.561B
YoY Change	26.99%	30.14%
SHAREHOLDERS EQUITY
Retained Earnings	$657.0M	$815.0M
YoY Change	-19.39%	19.42%
Common Stock	$865.0M	$822.0M
YoY Change	5.23%	5.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.521B	$1.641B
YoY Change
Total Liabilities & Shareholders Equity	$8.583B	$7.202B
YoY Change	19.18%	25.55%

Cashflow Statement

Concept	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	-$230.0M	$33.00M
YoY Change	-796.97%	-15.38%
Depreciation, Depletion And Amortization	$47.00M	$45.00M
YoY Change	4.44%	52.54%
Cash From Operating Activities	-$47.00M	$139.0M
YoY Change	-133.81%	47.72%
INVESTING ACTIVITIES
Capital Expenditures	-$34.00M	-$56.00M
YoY Change	-39.29%	36.92%
Acquisitions
YoY Change
Other Investing Activities	-$472.0M	$97.00M
YoY Change	-586.6%	-133.66%
Cash From Investing Activities	-$506.0M	$41.00M
YoY Change	-1334.15%	-112.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	334.0M	9.000M
YoY Change	3611.11%	-97.62%
NET CHANGE
Cash From Operating Activities	-47.00M	139.0M
Cash From Investing Activities	-506.0M	41.00M
Cash From Financing Activities	334.0M	9.000M
Net Change In Cash	-219.0M	189.0M
YoY Change	-215.87%	31.25%
FREE CASH FLOW
Cash From Operating Activities	-$47.00M	$139.0M
Capital Expenditures	-$34.00M	-$56.00M
Free Cash Flow	-$13.00M	$195.0M
YoY Change	-106.67%	44.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q2	moh	Amount Of Current Year Quality Incentive Premium Revenue Recognized AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized	29000000	USD
CY2017Q2	moh	Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable Prior Years AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayablePriorYears	-546000000	USD
CY2017Q2	moh	Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Not Recognized Current Year AffordableCareActPremiumStabilizationProgramRiskCorridorReceivableNotRecognizedCurrentYear	76000000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001179929
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	57118000	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	MOLINA HEALTHCARE INC
	dei	Trading Symbol TradingSymbol	moh
CY2016Q4	moh	Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayable	-1000000	USD
CY2017Q2	moh	Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayable	-5000000	USD
CY2017Q2	moh	Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable Current Year AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayableCurrentYear	-3000000	USD
CY2017Q2	moh	Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable Prior Years AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayablePriorYears	-2000000	USD
CY2016Q4	moh	Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayable	55000000	USD
CY2017Q2	moh	Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayable	57000000	USD
CY2017Q2	moh	Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable Current Year AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayableCurrentYear	0	USD
CY2017Q2	moh	Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable Prior Years AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayablePriorYears	57000000	USD
CY2016Q4	moh	Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayable	-522000000	USD
CY2017Q2	moh	Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayable	-1048000000	USD
CY2017Q2	moh	Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable Current Year AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayableCurrentYear	-502000000	USD
CY2017Q2	moh	Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Not Recognized Prior Years AffordableCareActPremiumStabilizationProgramRiskCorridorReceivableNotRecognizedPriorYears	52000000	USD
CY2016Q4	moh	Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayable	-1000000	USD
CY2017Q2	moh	Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayable	-1000000	USD
CY2017Q2	moh	Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable Current Year AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayableCurrentYear	0	USD
CY2017Q2	moh	Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable Prior Years AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayablePriorYears	-1000000	USD
	moh	Amortization Of Debt Discount Premium And Sale Leaseback Financing Obligation AmortizationOfDebtDiscountPremiumAndSaleLeasebackFinancingObligation	15000000	USD
	moh	Amortization Of Debt Discount Premium And Sale Leaseback Financing Obligation AmortizationOfDebtDiscountPremiumAndSaleLeasebackFinancingObligation	16000000	USD
CY2016Q2	moh	Amount Of Current Year Quality Incentive Premium Revenue Recognized AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized	36000000	USD
	moh	Amount Of Current Year Quality Incentive Premium Revenue Recognized AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized	54000000	USD
	moh	Amount Of Current Year Quality Incentive Premium Revenue Recognized AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized	48000000	USD
CY2016Q2	moh	Amount Of Quality Incentive Premium Revenue Recognized From Prior Year AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear	49000000	USD
	moh	Amount Of Quality Incentive Premium Revenue Recognized From Prior Year AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear	54000000	USD
CY2017Q2	moh	Amount Of Quality Incentive Premium Revenue Recognized From Prior Year AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear	1000000	USD
	moh	Amount Of Quality Incentive Premium Revenue Recognized From Prior Year AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear	6000000	USD
	moh	Business Combination Prepaid Consideration Transferred BusinessCombinationPrepaidConsiderationTransferred	102000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	8000000	USD
	moh	Business Combination Prepaid Consideration Transferred BusinessCombinationPrepaidConsiderationTransferred	0	USD
	moh	Business Combination Purchase Price Amounts Accrued Received BusinessCombinationPurchasePriceAmountsAccruedReceived	21000000	USD
	moh	Business Combination Purchase Price Amounts Accrued Received BusinessCombinationPurchasePriceAmountsAccruedReceived	0	USD
CY2016Q4	moh	Capitation Claims Payable CapitationClaimsPayable	37000000	USD
CY2017Q2	moh	Capitation Claims Payable CapitationClaimsPayable	45000000	USD
	moh	Changes In Amounts Due To And Due From Affiliates ChangesInAmountsDueToAndDueFromAffiliates	0	USD
	moh	Changes In Amounts Due To And Due From Affiliates ChangesInAmountsDueToAndDueFromAffiliates	0	USD
CY2017Q2	moh	Class Of Warrant Or Right Stated Percentage ClassOfWarrantOrRightStatedPercentage	0.01125
CY2016Q2	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	50000000	USD
	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	108000000	USD
CY2017Q2	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	0	USD
	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	0	USD
CY2016Q2	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	76000000	USD
	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	166000000	USD
CY2017Q2	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	0	USD
	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	0	USD
CY2016Q2	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	109000000	USD
	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	218000000	USD
CY2017Q2	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	114000000	USD
	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	225000000	USD
CY2016Q4	moh	Health Care Reform Premium Deficiency Reserve HealthCareReformPremiumDeficiencyReserve	30000000	USD
CY2017Q2	moh	Health Care Reform Premium Deficiency Reserve HealthCareReformPremiumDeficiencyReserve	100000000	USD
	moh	Increase Decrease In Medical Premium Liability Due To Agency IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency	509000000	USD
	moh	Increase Decrease In Medical Premium Liability Due To Agency IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency	642000000	USD
CY2016Q2	moh	Maximum Available Quality Incentive Premium Current Year MaximumAvailableQualityIncentivePremiumCurrentYear	41000000	USD
	moh	Maximum Available Quality Incentive Premium Current Year MaximumAvailableQualityIncentivePremiumCurrentYear	81000000	USD
CY2017Q2	moh	Maximum Available Quality Incentive Premium Current Year MaximumAvailableQualityIncentivePremiumCurrentYear	39000000	USD
	moh	Maximum Available Quality Incentive Premium Current Year MaximumAvailableQualityIncentivePremiumCurrentYear	77000000	USD
CY2016Q4	moh	Medical Claims And Benefits Payable MedicalClaimsAndBenefitsPayable	225000000	USD
CY2017Q2	moh	Medical Claims And Benefits Payable MedicalClaimsAndBenefitsPayable	111000000	USD
	moh	Medical Claims And Benefits Payable Adjustments Change In Provider MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider	24000000	USD
	moh	Medical Claims And Benefits Payable Adjustments Change In Provider MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider	-114000000	USD
CY2016Q4	moh	Medical Premium Liability Due To Agency MedicalPremiumLiabilityDueToAgency	1202000000	USD
CY2017Q2	moh	Medical Premium Liability Due To Agency MedicalPremiumLiabilityDueToAgency	1844000000	USD
CY2016Q2	moh	Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest	33000000	USD
	moh	Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest	57000000	USD
CY2017Q2	moh	Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest	-230000000	USD
	moh	Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest	-153000000	USD
	moh	Number Of Members Added NumberOfMembersAdded	400000	member
CY2016Q4	moh	Other Claims Payable OtherClaimsPayable	428000000	USD
CY2017Q2	moh	Other Claims Payable OtherClaimsPayable	433000000	USD
CY2016Q4	moh	Pharmacy Claims Payable PharmacyClaimsPayable	112000000	USD
CY2017Q2	moh	Pharmacy Claims Payable PharmacyClaimsPayable	121000000	USD
	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.113
	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.016
	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.014
	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.002
	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.013
	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.002
CY2016Q2	moh	Premium Tax Expenses PremiumTaxExpenses	109000000	USD
	moh	Premium Tax Expenses PremiumTaxExpenses	218000000	USD
CY2017Q2	moh	Premium Tax Expenses PremiumTaxExpenses	114000000	USD
	moh	Premium Tax Expenses PremiumTaxExpenses	225000000	USD
CY2016Q2	moh	Quality Incentive Premium Revenue As A Percentage Of Total Revenue QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue	0.021
	moh	Quality Incentive Premium Revenue As A Percentage Of Total Revenue QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue	0.013
CY2017Q2	moh	Quality Incentive Premium Revenue As A Percentage Of Total Revenue QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue	0.006
	moh	Quality Incentive Premium Revenue As A Percentage Of Total Revenue QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue	0.006
CY2016Q2	moh	Quality Incentive Premium Revenue Recognized QualityIncentivePremiumRevenueRecognized	85000000	USD
	moh	Quality Incentive Premium Revenue Recognized QualityIncentivePremiumRevenueRecognized	108000000	USD
CY2017Q2	moh	Quality Incentive Premium Revenue Recognized QualityIncentivePremiumRevenueRecognized	30000000	USD
	moh	Quality Incentive Premium Revenue Recognized QualityIncentivePremiumRevenueRecognized	54000000	USD
	moh	Unrecognized Compensation Forfeited Rate UnrecognizedCompensationForfeitedRate	0.033
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	385000000	USD
CY2017Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	375000000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2000000	USD
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1000000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	841000000	USD
CY2017Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	865000000	USD
CY2016Q2	us-gaap	Administrative Services Revenue AdministrativeServicesRevenue	13000000	USD
	us-gaap	Administrative Services Revenue AdministrativeServicesRevenue	27000000	USD
CY2017Q2	us-gaap	Administrative Services Revenue AdministrativeServicesRevenue	13000000	USD
	us-gaap	Administrative Services Revenue AdministrativeServicesRevenue	26000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	35000000	USD
CY2016Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	1492000000	USD
CY2017Q2	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	1526000000	USD
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1000000	shares
CY2016Q4	us-gaap	Assets Assets	7449000000	USD
CY2017Q2	us-gaap	Assets Assets	8583000000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	5988000000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	7169000000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1761000000	USD
CY2017Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2518000000	USD
CY2016Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1758000000	USD
CY2017Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	2517000000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1000000	USD
CY2017Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2000000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4000000	USD
CY2017Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3000000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2017Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	4000000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1193000000	USD
CY2017Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	3000000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	841000000	USD
CY2017Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	1160000000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2017Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	23000000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	23000000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1194000000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	2517000000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	1301000000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	1301000000	USD
CY2016Q4	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	580	Security
CY2017Q2	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	519	Security
CY2016Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	0	Security
CY2017Q2	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	0	Security
CY2016Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	1000000	USD
CY2017Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	1000000	USD
CY2016Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	198000000	USD
CY2017Q2	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	198000000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2329000000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2345000000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2819000000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2979000000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	16000000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	160000000	USD
CY2013Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	53.8475
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57000000	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57000000	shares
CY2016Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	0	USD
CY2017Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	0	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	35000000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	65000000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-230000000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-152000000	USD
CY2016Q2	us-gaap	Costs And Expenses CostsAndExpenses	4254000000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	8508000000	USD
CY2017Q2	us-gaap	Costs And Expenses CostsAndExpenses	5286000000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	10108000000	USD
CY2016Q4	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	86000000	USD
CY2017Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	93000000	USD
CY2013	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	13490236	shares
CY2016Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	6000000	USD
CY2017Q2	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	7000000	USD
CY2016Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	11000000	USD
CY2017Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	13000000	USD
CY2016Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	10000000	USD
CY2017Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	36000000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	315000000	USD
CY2017Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	284000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	15000000	USD
CY2017Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	0	USD
CY2016Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	34000000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	66000000	USD
CY2017Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	37000000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	76000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	89000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	96000000	USD
CY2016Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	267000000	USD
CY2017Q2	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	440000000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
CY2016Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	267000000	USD
CY2017Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	440000000	USD
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.58
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.02
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.74
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.01
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.74
CY2017Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	32000000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	131000000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	140000000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	112000000	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	351000000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	691000000	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	405000000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	844000000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	620000000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	559000000	USD
CY2016Q2	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2017Q2	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	72000000	USD
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	72000000	USD
CY2016Q4	us-gaap	Goodwill Gross GoodwillGross	678000000	USD
CY2016Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	58000000	USD
CY2017Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	119000000	USD
CY2016	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	61000000	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	454000000	USD
	us-gaap	Gross Profit GrossProfit	874000000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	254000000	USD
	us-gaap	Gross Profit GrossProfit	800000000	USD
CY2016Q2	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	4029000000	USD
	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	8024000000	USD
CY2017Q2	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	4740000000	USD
	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	9388000000	USD
CY2017Q2	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	118000000	USD
CY2017Q2	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	17000000	USD
CY2017Q2	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	18000000	USD
CY2017Q2	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	100000000	USD
CY2017Q2	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	100000000	USD
CY2017Q2	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	117000000	USD
CY2016	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2017Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	11000000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	80000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	144000000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-314000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-183000000	USD
CY2016Q2	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	0	USD
	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	0	USD
CY2017Q2	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	0	USD
	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	0	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	47000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	87000000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-84000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-30000000	USD
CY2016Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	39000000	USD
CY2017Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	68000000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	147000000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-18000000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-10000000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-30000000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-39000000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	41000000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-119000000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-32000000	USD
	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	82000000	USD
	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	148000000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	143000000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	38000000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	415000000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	32000000	USD
	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	-5000000	USD
	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	10000000	USD
CY2016Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1000000	shares
CY2017Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2016Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	760000000	USD
CY2017Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	671000000	USD
CY2016Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	10000000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	19000000	USD
CY2017Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	16000000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	30000000	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	25000000	USD
	us-gaap	Interest Expense InterestExpense	50000000	USD
CY2017Q2	us-gaap	Interest Expense InterestExpense	27000000	USD
	us-gaap	Interest Expense InterestExpense	53000000	USD
CY2016Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2017Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2016Q4	us-gaap	Liabilities Liabilities	5800000000	USD
CY2017Q2	us-gaap	Liabilities Liabilities	7062000000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7449000000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8583000000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4570000000	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5793000000	USD
CY2015Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1685000000	USD
CY2016Q2	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1766000000	USD
CY2016Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1929000000	USD
CY2017Q2	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	2077000000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	5885000000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	6883000000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	1240000000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	1457000000	USD
CY2016Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	1352000000	USD
CY2017Q2	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	1478000000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	7182000000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	8602000000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1173000000	USD
CY2017Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1215000000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	472000000	USD
CY2017Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	773000000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	1645000000	USD
CY2017Q2	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	1988000000	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	975000000	USD
CY2017Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1017000000	USD
CY2016Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1758000000	USD
CY2017Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2192000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	333000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-273000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-845000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	278000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	672000000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	33000000	USD
	us-gaap	Net Income Loss NetIncomeLoss	57000000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-230000000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-153000000	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-25000000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-50000000	USD
CY2017Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-27000000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	22000000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	Segment
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	105000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	194000000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-287000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-205000000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	41000000	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	47000000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2000000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1000000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	4000000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	13000000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1000000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	2000000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	5000000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	42000000	USD
CY2017Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	54000000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	75000000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	11000000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	7000000	USD
	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	7125000000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	6000000	USD
	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	8000000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	13000000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	3000000	USD
	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	0	USD
	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	8340000000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	974000000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1636000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	102000000	USD
CY2016Q2	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	3594000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	60000000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	7182000000	USD
CY2017Q2	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	4491000000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	8602000000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	131000000	USD
CY2017Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	159000000	USD
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	0	USD
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	325000000	USD
	us-gaap	Proceeds From Dividends Received ProceedsFromDividendsReceived	0	USD
	us-gaap	Proceeds From Dividends Received ProceedsFromDividendsReceived	0	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	10000000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	11000000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	1000000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-3000000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	812000000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	874000000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	454000000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	449000000	USD
CY2016Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	974000000	USD
CY2017Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	1006000000	USD
CY2016Q4	us-gaap	Reinsurance Recoverable For Unpaid Claims And Claims Adjustments ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments	83000000	USD
CY2017Q2	us-gaap	Reinsurance Recoverable For Unpaid Claims And Claims Adjustments ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments	65000000	USD
CY2016Q4	us-gaap	Related Party Transaction Due From To Related Party Current RelatedPartyTransactionDueFromToRelatedPartyCurrent	0	USD
CY2017Q2	us-gaap	Related Party Transaction Due From To Related Party Current RelatedPartyTransactionDueFromToRelatedPartyCurrent	0	USD
CY2016Q4	us-gaap	Restricted Investments Current RestrictedInvestmentsCurrent	0	USD
CY2017Q2	us-gaap	Restricted Investments Current RestrictedInvestmentsCurrent	325000000	USD
CY2016Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	110000000	USD
CY2017Q2	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	118000000	USD
	us-gaap	Restructuring And Related Cost Expected Number Of Positions Eliminated RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated	1500	position
CY2017Q2	us-gaap	Restructuring Charges RestructuringCharges	43000000	USD
	us-gaap	Restructuring Charges RestructuringCharges	43000000	USD
CY2016Q2	us-gaap	Restructuring Costs RestructuringCosts	0	USD
	us-gaap	Restructuring Costs RestructuringCosts	0	USD
CY2017Q2	us-gaap	Restructuring Costs RestructuringCosts	43000000	USD
	us-gaap	Restructuring Costs RestructuringCosts	43000000	USD
CY2016Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	USD
CY2017Q2	us-gaap	Restructuring Reserve RestructuringReserve	17000000	USD
	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	23000000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	810000000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	657000000	USD
CY2016Q2	us-gaap	Revenues Revenues	4359000000	USD
	us-gaap	Revenues Revenues	8702000000	USD
CY2017Q2	us-gaap	Revenues Revenues	4999000000	USD
	us-gaap	Revenues Revenues	9903000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	16000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	35000000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	23000000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	58643	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	54.48
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	608176	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	56.98
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	922900	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	691455	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	58.15
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	57.57
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	780978	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	57.63
CY2017Q2	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	1662000000	USD
CY2017Q2	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	1118000000	USD
	us-gaap	Stock Issued1 StockIssued1	7000000	USD
	us-gaap	Stock Issued1 StockIssued1	21000000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	24000000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	1649000000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	1521000000	USD
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-128000000	USD
	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	7371000000	USD
	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	8633000000	USD
	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-189000000	USD
	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-31000000	USD
CY2016Q2	us-gaap	Technology Services Costs TechnologyServicesCosts	116000000	USD
	us-gaap	Technology Services Costs TechnologyServicesCosts	243000000	USD
CY2017Q2	us-gaap	Technology Services Costs TechnologyServicesCosts	124000000	USD
	us-gaap	Technology Services Costs TechnologyServicesCosts	246000000	USD
CY2016Q2	us-gaap	Technology Services Revenue TechnologyServicesRevenue	135000000	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	275000000	USD
CY2017Q2	us-gaap	Technology Services Revenue TechnologyServicesRevenue	129000000	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	260000000	USD
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56000000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56000000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55000000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56000000	shares
	us-gaap	Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table provides the details of our medical claims and benefits payable (including amounts payable for the provision of long-term services and supports, or LTSS) as of the dates indicated.</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">June 30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">December 31,<br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">(In millions)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Fee-for-service claims incurred but not paid (IBNP)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,478</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,352</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Pharmacy payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">121</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">112</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Capitation payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">433</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">428</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,077</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,929</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

Files In Submission

Name	View Source	Status
0001179929-17-000172-index-headers.html	Edgar Link	pending
0001179929-17-000172-index.html	Edgar Link	pending
0001179929-17-000172.txt	Edgar Link	pending
0001179929-17-000172-xbrl.zip	Edgar Link	pending
a2017amendedrestatedemploy.htm	Edgar Link	pending
a6302017-10qex311.htm	Edgar Link	pending
a6302017-10qex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
moh-20170630.xml	Edgar Link	completed
moh-20170630.xsd	Edgar Link	pending
moh-20170630_cal.xml	Edgar Link	unprocessable
moh-20170630_def.xml	Edgar Link	unprocessable
moh-20170630_lab.xml	Edgar Link	unprocessable
moh-20170630_pre.xml	Edgar Link	unprocessable
moh-33120_chartx55244a01.jpg	Edgar Link	pending
moh-6302017x10q.htm	Edgar Link	pending
moh-63020_chartx34844.jpg	Edgar Link	pending
moh330mindenture.htm	Edgar Link	pending
mohpurchaseagreement052220.htm	Edgar Link	pending
mohthirdamendmentcreditagr.htm	Edgar Link	pending
molinalogo2016a18.jpg	Edgar Link	pending
molinalogo2016a21.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
waiverrelease-drmolinafinal.htm	Edgar Link	pending
waiverrelease-johnmolinafi.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MOH
MOLINA HEALTHCARE, INC. Stock $moh

2017 Q2 Form 10-Q Financial Statement

#000117992917000172 Filed on August 02, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH MOLINA HEALTHCARE, INC. Stock $moh

2017 Q2 Form 10-Q Financial Statement

#000117992917000172 Filed on August 02, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH
MOLINA HEALTHCARE, INC. Stock $moh